• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于重组复制缺陷腺病毒的狂犬病疫苗]

[Recombinant replication-defective adenovirus based rabies vaccine].

作者信息

Li Wen-hui, Zhang Yun, Wang Shu-hui, Liu Li, Yang Fan

机构信息

Department of Etiology, Institute of Basic Medical Science, CAMS and PUMC, Beijing 100005, China.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Dec;25(6):650-4.

PMID:14714304
Abstract

OBJECTIVE

To construct and characterize recombinant adenoviruses containing glycoprotein (GP) gene from rabies virus CVS-N2C strain.

METHODS

To obtain the recombinant adenovirus by pAdEasy system, identify recombinant virus with cDNA sequencing, Northern blot, Dot blot, Western blot and challenge-protection experiment of mice.

RESULTS

Recombinant adenovirus showed typical adenovirus morphological characteristics; the viral genome was stable; GP specific mRNA and presence of glycoprotein were determined in rAdGPcvs and rAdGPcvs' infected cells. The glycoprotein produced by recombinant adenovirus had a molecular mass of 66,000, which was similar to that of natural glycoprotein. In the group of rAdGPcvs immunized mice, 87.5%-100% of mice survived from a 35.8LD50/38.0LD50 lethal rabies intracerebral challenge. Finally 73.3%-83.3% of the mice that had received eAdGPcvs survived, and all the Ad5 immunized mice succumbed to rabies.

CONCLUSION

Recombinant adenovirus rAdGPcvs and rAdGPcvs' hold great potential to be developed as recombinant rabies vaccines, and at the same time, it is actually the first study that on high neuropathogenicity rabies CVS-N2C glycoprotein based adenoviral recombinants.

摘要

目的

构建并鉴定含狂犬病病毒CVS-N2C株糖蛋白(GP)基因的重组腺病毒。

方法

采用pAdEasy系统获得重组腺病毒,通过cDNA测序、Northern印迹、斑点印迹、Western印迹及小鼠攻毒保护实验对重组病毒进行鉴定。

结果

重组腺病毒呈现典型的腺病毒形态特征;病毒基因组稳定;在rAdGPcvs和rAdGPcvs'感染的细胞中检测到GP特异性mRNA及糖蛋白的存在。重组腺病毒产生的糖蛋白分子量为66000,与天然糖蛋白相似。在rAdGPcvs免疫的小鼠组中,87.5%-100%的小鼠在接受35.8LD50/38.0LD50致死量的狂犬病脑内攻毒后存活。最后,接受eAdGPcvs的小鼠中有73.3%-83.3%存活,而所有接种Ad5的小鼠均死于狂犬病。

结论

重组腺病毒rAdGPcvs和rAdGPcvs'具有开发成为重组狂犬病疫苗的巨大潜力,同时,这实际上是首次对基于高神经致病性狂犬病CVS-N2C糖蛋白的腺病毒重组体进行的研究。

相似文献

1
[Recombinant replication-defective adenovirus based rabies vaccine].[基于重组复制缺陷腺病毒的狂犬病疫苗]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Dec;25(6):650-4.
2
Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.E3缺失腺病毒重组体对狂犬病病毒3aG株糖蛋白基因的表达
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Sep;14(3):281-4.
3
[Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].[小鼠对含狂犬病病毒3aG株糖蛋白基因的复制缺陷型重组腺病毒的免疫反应]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Mar;15(1):61-5.
4
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.一种复制缺陷型人腺病毒重组体可作为一种高效的疫苗载体。
Virology. 1996 May 1;219(1):220-7. doi: 10.1006/viro.1996.0239.
5
[Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].[表达狂犬病糖蛋白的非复制型重组痘苗病毒的构建与鉴定]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999 Jun 30;13(2):170-4.
6
Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.当从非复制性腺病毒重组体中表达时,来自街狂犬病毒BD06的糖蛋白可诱导早期且强烈的免疫反应。
Arch Virol. 2015 Sep;160(9):2315-23. doi: 10.1007/s00705-015-2512-1. Epub 2015 Jul 5.
7
Canine adenovirus based rabies vaccines.基于犬腺病毒的狂犬病疫苗。
Dev Biol (Basel). 2008;131:467-76.
8
[Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].[携带狂犬病病毒糖蛋白外部区域的重组犬2型腺病毒的构建及免疫原性]
Wei Sheng Wu Xue Bao. 2005 Apr;45(2):213-7.
9
Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.一种用于狂犬病的重组改良安卡拉痘苗病毒疫苗的产生与评估。
Vaccine. 2007 May 22;25(21):4213-22. doi: 10.1016/j.vaccine.2007.02.084. Epub 2007 Mar 22.
10
A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.用表达狂犬病病毒G蛋白的重组犬腺病毒进行单次免疫可使小鼠获得抗狂犬病的保护性免疫。
Virology. 2006;356(1-2):147-54. doi: 10.1016/j.virol.2006.07.037. Epub 2006 Aug 30.

引用本文的文献

1
Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.病毒载体对体外迁移传入淋巴管树突状细胞的差异影响预测了体内增强的免疫原性。
J Virol. 2011 Sep;85(18):9385-94. doi: 10.1128/JVI.05127-11. Epub 2011 Jul 13.
2
Development of adenoviral vector-based mucosal vaccine against influenza.基于腺病毒载体的流感黏膜疫苗的研制。
J Mol Med (Berl). 2011 Apr;89(4):331-41. doi: 10.1007/s00109-010-0696-0. Epub 2010 Nov 21.
3
The cell biology of rabies virus: using stealth to reach the brain.
狂犬病病毒的细胞生物学:利用隐身术到达大脑。
Nat Rev Microbiol. 2010 Jan;8(1):51-61. doi: 10.1038/nrmicro2260.
4
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.基于复制缺陷型狂犬病病毒的疫苗在小鼠和非人灵长类动物中是安全且具有免疫原性的。
J Infect Dis. 2009 Oct 15;200(8):1251-60. doi: 10.1086/605949.
5
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.表达两个拷贝狂犬病病毒糖蛋白基因的磷蛋白缺失狂犬病病毒疫苗载体的免疫调节作用
Vaccine. 2008 Nov 25;26(50):6405-14. doi: 10.1016/j.vaccine.2008.08.069. Epub 2008 Sep 18.